Repository logo

Acid-sensing ion channel 3: An analgesic target.

Published version

Change log



Acid-sensing ion channel 3 (ASIC3) belongs to the epithelial sodium channel/degenerin (ENaC/DEG) superfamily. There are 7 different ASIC subunits encoded by 5 different genes. Most ASIC subunits form trimeric ion channels that upon activation by extracellular protons mediate a transient inward current inducing cellular excitability. ASIC subunits exhibit differential tissue expression and biophysical properties, and the ability of subunits to form homo- and heteromeric trimers further increases the complexity of currents measured and their pharmacological properties. ASIC3 is of particular interest, not only because it exhibits high expression in sensory neurones, but also because upon activation it does not fully inactivate: a transient current is followed by a sustained current that persists during a period of extracellular acidity, i.e. ASIC3 can encode prolonged acidosis as a nociceptive signal. Furthermore, certain mediators sensitize ASIC3 enabling smaller proton concentrations to activate it and other mediators can directly activate the channel at neutral pH. Moreover, there is a plethora of evidence using transgenic mouse models and pharmacology, which supports ASIC3 as being a potential target for development of analgesics. This review will focus on current understanding of ASIC3 function to provide an overview of how ASIC3 contributes to physiology and pathophysiology, examining the mechanisms by which it can be modulated, and highlighting gaps in current understanding and future research directions.



Acidosis, acid-Sensing Ion Channel 3, analgesia, asic3, inflammation, ion channels, nociception, pH, pain, Analgesics, Animals, CHO Cells, Cricetulus, Epithelial Sodium Channels, Hydrogen-Ion Concentration, Ion Transport, Mice

Journal Title

Channels (Austin)

Conference Name

Journal ISSN


Volume Title



Informa UK Limited
Biotechnology and Biological Sciences Research Council (BB/R006210/1)
Arthritis Research UK (11600/21973)
Work in the Smith Lab is supported by Versus Arthritis Research Grant (RG21973) and Biotechnology and Biological Sciences Research Council grant (BB/R006210/1).